Literature DB >> 11322123

Subependymal giant cell astrocytoma: clinical and neuroimaging features of four cases.

S Nishio1, T Morioka, S Suzuki, R Kira, F Mihara, M Fukui.   

Abstract

The clinical history, neuroimaging features, treatments, and outcome of 4 patients with histologically verified subependymal giant cell astrocytomas (SEGA) were retrospectively reviewed. The average age at the time of surgery was 13.3 years. Headache related to raised intracranial pressure was the first and only sign in 2 patients, with the remaining 2 being admitted because of sequential neuroimaging studies over several years revealing the growth of 'subependymal nodules' into intraventricular tumours. In each case the tumour was in the region of Monro's foramen and was associated with ventricular dilatation. On computed tomography (CT), multiple subependymal nodules were found in 3 patients, and these well circumscribed isodense SEGAs were markedly enhanced by contrast medium. On magnetic resonance imaging (MRI), which was obtained in 3 patients, 2 SEGAs were isointense with the cerebral cortex and one with the white matter on T1-weighted images, and on T2-weighted images, 2 were isointense with the cortex and one with the white matter. At surgery the tumours appeared to originate from the inferolateral wall of the lateral ventricle in the region of the head of the caudate nuclei. Total macroscopic removal was achieved in 3 patients, and subtotal removal in one patient. Follow up ranged from 4.6 to 13.2 years, and all patients have exhibited similar physical and mental conditions to preoperative. So far there has been no evidence of any recurrences. The diagnosis and the surgical indications for SEGA are discussed, with periodic monitoring with neuroimaging studies being recommended even for asymptomatic patients with 'subependymal nodules'.

Entities:  

Mesh:

Year:  2001        PMID: 11322123     DOI: 10.1054/jocn.2000.0767

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  7 in total

Review 1.  Insights into molecular therapy of glioma: current challenges and next generation blueprint.

Authors:  Y Rajesh; Ipsita Pal; Payel Banik; Sandipan Chakraborty; Sachin A Borkar; Goutam Dey; Ahona Mukherjee; Mahitosh Mandal
Journal:  Acta Pharmacol Sin       Date:  2017-03-20       Impact factor: 6.150

2.  Tuberous sclerosis complex; single center experience.

Authors:  İlknur Erol; Tülin Savaş; Sevda Şekerci; Nalan Yazıcı; Ayşe Erbay; Şenay Demir; Semra Saygı; Özlem Alkan
Journal:  Turk Pediatri Ars       Date:  2015-03-01

3.  Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma.

Authors:  Heon You; Young Im Kim; Soo Young Im; Haeyoung Suh-Kim; Sun Ha Paek; Sung-Hye Park; Dong Gyu Kim; Hee-Won Jung
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

4.  Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex.

Authors:  Martine Fohlen; Sarah Ferrand-Sorbets; Olivier Delalande; Georg Dorfmüller
Journal:  Childs Nerv Syst       Date:  2018-05-15       Impact factor: 1.475

5.  Subependymal giant cell astrocytoma: a report of five cases.

Authors:  Raj Kumar; Vinita Singh
Journal:  Neurosurg Rev       Date:  2004-08-12       Impact factor: 3.042

6.  Association between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex.

Authors:  Jeng-Dau Tsai; Chang-Ching Wei; Teng-Fu Tsao; Yu-Ping Hsiao; Henry J Tsai; Sheng-Hui Yang; Min-Ling Tsai; Ji-Nan Sheu
Journal:  Childs Nerv Syst       Date:  2015-11-09       Impact factor: 1.475

Review 7.  Subependymal giant cell astrocytoma (SEGA): a case report and review of the literature.

Authors:  Layla Tahiri Elousrouti; Meryem Lamchahab; Nawal Bougtoub; Hinde Elfatemi; Laila Chbani; Taoufik Harmouch; Mustapha Maaroufi; Afaf Amarti Riffi
Journal:  J Med Case Rep       Date:  2016-02-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.